Ritonavir 100mg tabs/PAC-30

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Ritonavir 100mg film coated tablets, bottle pack of 30

Technical Specifications:
Each film coated tablet contains Ritonavir 100mg

Therapeutic class:
Ritonavir is a protease inhibitor (PI)

Standard shelf life:
24 Months

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines

and

WHO Essential Medicines Library

or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:

WHO HIV/AIDS

WHO Generic tool for assessing paediatric ARV dosing

Indications:
Management of HIV-1 infection in children and adults as a booster to increase effect of Atazanavir, Darunavir, Indinavir, Lopinavir or Saquinavir and in additional combination with two other antiretroviral drugs. By mouth (oral) PO.

Packaging and storage:
Do not store above 25ºC (77°F), protect from light.
Store in tightly closed original container.
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack.

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines

List of USFDA approved and tentatively approved items

Important information regarding supply for this product

Please click on the link:
http://www.unicef.org/supply/index_81996.html